Adjunct therapies during mechanical ventilation: Airway clearance techniques, therapeutic aerosols, and gases

Respiratory Care

Volumn 58, Issue 6, 2013, Pages 1053-1071

  Kallet, Richard H ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

Aerosolized heparin; Aerosolized prostacyclin; Heliox; High frequency percussive ventilation; Inhaled nitric oxide; Intrapulmonary percussive ventilation; Metered dose inhalers

Indexed keywords

ACETYLCYSTEINE; AMIKACIN; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CEFTAZIDIME; CHLOROFLUOROCARBON; COLISTIN; CORTICOSTEROID; FLUORINATED HYDROCARBON; HELIOX; HEPARIN; NITRIC OXIDE; PLACEBO; PROSTACYCLIN; PROSTAGLANDIN E1; TOBRAMYCIN; VASODILATOR AGENT;

ACINETOBACTER INFECTION; ADULT RESPIRATORY DISTRESS SYNDROME; AEROSOL; AIRWAY OBSTRUCTION; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; ATELECTASIS; BREATHING EXERCISE; BREATHING PATTERN; CHILD HEALTH CARE; CILIARY MOTILITY; CLINICAL EFFECTIVENESS; CORTICOSTEROID THERAPY; CRITICALLY ILL PATIENT; CYSTIC FIBROSIS; DISEASE MODEL; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EVIDENCE BASED PRACTICE; HIGH FREQUENCY OSCILLATION; HUMAN; HUMIDIFIER; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; INTRAPULMONARY PERCUSSIVE VENTILATION; LUNG BURN; LUNG CLEARANCE; LUNG DISEASE; LUNG GAS EXCHANGE; LUNG INJURY; LUNG TOXICITY; MECHANICAL INSUFFLATION EXSUFFLATION; MECONIUM ASPIRATION; METERED DOSE INHALER; METHEMOGLOBINEMIA; MULTIDRUG RESISTANCE; NEBULIZER; NEPHROTOXICITY; NONHUMAN; PALLIATIVE THERAPY; PNEUMOCYSTOSIS; POSITIVE END EXPIRATORY PRESSURE; PSEUDOMONAS INFECTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY AIRFLOW; RESPIRATORY FAILURE; SEPSIS; TIDAL VOLUME; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VENTILATOR ASSOCIATED PNEUMONIA;

AEROSOLIZED HEPARIN; AEROSOLIZED PROSTACYCLIN; HELIOX; HIGH-FREQUENCY PERCUSSIVE VENTILATION; INHALED NITRIC OXIDE; INTRAPULMONARY PERCUSSIVE VENTILATION; METERED-DOSE INHALERS;

AEROSOLS; ANTI-BACTERIAL AGENTS; DRAINAGE; FIBRINOLYTIC AGENTS; FREE RADICAL SCAVENGERS; HELIUM; HEPARIN; HUMANS; INSUFFLATION; METERED DOSE INHALERS; MUCUS; NEBULIZERS AND VAPORIZERS; NITRIC OXIDE; OXYGEN; PNEUMONIA, VENTILATOR-ASSOCIATED; PROSTAGLANDINS; RESPIRATION, ARTIFICIAL; RESPIRATORY THERAPY; VASODILATOR AGENTS;

EID: 84878408655     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.02217     Document Type: Article

References (119)

1. Toussaint M, DeWin H, Steens M, Soudon P. Effect of intrapulmonary percussive ventilation on mucus clearance in Duchenne muscular dystrophy patients: a preliminary report. Respir Care 2003; 48(10):940-947.
2. Cioffi WG, Graves TA, McManus WF, Pruitt BA. High-frequency percussive ventilation in patients with inhalation injury. J Trauma 1989;29(3):350-354.
3. Davis K, Hurst JM, Branson RD. High frequency percussive ventilation. Prob Respir Care 1989;2(1):39-47.
4. Reper P, Dankaert F, van Hille F, van Laeke P, Duinslaeger L, Vanderkelen A. The usefulness of combined high-frequency percussive ventilation during acute respiratory failure after smoke inhalation. Burns 1998;24(1):34-38.
5. Reper P, Wilbaux O, van Laeke P, Vandeenen D, Duinslaeger L, Vanderkelen A. High frequency percussive ventilation and conventional ventilation after smoke inhalation: a randomized study. Burns 2002;28(5):503-508.
6. Freitag L, Schroer M, Brenne J. High-frequency oscillators with adjustable waveforms: practical aspects. Br J Anaesth 1989;63(7): 38S-43S.
7. Freitag L, Long WM, Kim CS, Wanner A. Removal of excessive bronchial secretions by asymmetric high-frequency oscillations. J Appl Physiol 1989;67(2):614-619.
8. Kim CS, Rodriguez CR, Eldridge MA, Sackner MA. Criteria for mucus transport in the airways by two-phase gas liquid flow mechanism. J Appl Phsyiol 1986;60(3):901-907.
9. Tomkiewicz RP, Biviji A, King M. Effects of oscillating air flow on the rheologic properties and clearibility of mucous gel simulants. Biorheology 1994;31(5):511-520.
10. King M, Phillips DM, Gross D, Vartian V, Chang HK, Zidulka A. Enhanced tracheal mucus clearance with high frequency chest wall compression. Am Rev Respir Dis 1983;128(3):511-515.
11. George RJ, Johnson MA, Pavia D, Agnew JE, Clarke SW, Geddes DM. Increase in mucociliary clearance in normal man induced by oral high-frequency oscillation. Thorax 1985;40(6):433-437.
12. Clinkscale D, Spihlman K, Watta P, Rosenbluth D, Koellef MH. A randomized trial of conventional chest physical therapy versus highfrequency chest wall compressions in intubated and non-intubated adults. Respir Care 2012;57(2):221-228.
13. Lucangelo U, Antonaglia V, Zin WA, Confalonieri M, Borelli M, Columban M, et al. High-frequency percussive ventilation improves perioperatively clinical evolution in pulmonary resection. Crit Care Med 2009;37(5):1663-1669.
14. Antonaglia V, Lucangelo U, Zin WA, Peratoner A, DeSimoni L, Capitanio G, et al. Intrapulmonary percussive ventilation improves the outcome of patients with acute exacerbation of chronic obstructive pulmonary disease using a helmet. Crit Care Med 2006;34(12): 2940-2945.
15. Deakins K, Chatburn RL. A comparison of intrapulmonary percussive ventilation and conventional chest physiotherapy for the treatment of atelectasis in the pediatric patient. Respir Care 2002;47(10): 1162-1167.
16. Reper P, van Looy K. Chest physiotherapy using intrapulmonary percussive ventilation to treat persistent atelectasis in hypoxic patients after smoke inhalation. Burns 2013;39(1):192-193.
17. Tsuruta R, Kasaoka S, Okabayashi K, Maekawa T. Efficacy and safety of intrapulmonary percussive ventilation superimposed on conventional ventilation in obese patients with compression atelectasis. J Crit Care 2006;21(4):328-332.
18. Clini EM, Antoni FD, Vitacca M, Crisafulli E, Paneroni M, Chezzi-Silva S, et al. Intrapulmonary percussive ventilation in trachotomized patients: a randomized controlled trial. Intensive Care Med 2006;32(12):1994-2001.
19. Chung KK, Wolf SE, Renz EM, Allan PF, Aden JK, Merrill GA, et al. High-frequency percussive ventilation and low VT ventilation in burns: a randomized controlled trial. Crit Care Med 2010;38(10): 1970-1977.
20. Eastman A, Holland D, Higgins J, Smith B, Delagarza J, Olson C, et al. High-frequency percussive ventilation improves oxygenation in trauma patients with acute respiratory distress syndrome: a retrospective review. Am J Surg 2006;192(2):191-195.
21. Salim A, Miller K, Dangleben D, Cipolle M, Pasquale M. Highfrequency percussive ventilation: an alternative mode of ventilation for head-injured patients with adult respiratory distress syndrome. J Trauma 2004;57(3):542-546.
22. Velmahos GC, Chan LS, Tatevossian R, Cornwell EE, Dougherty WR, Escudero J, Demetriades D. High-frequency percussion ventilation improves oxygenation in patients with ARDS. Chest 1999; 116(2):440-446.
23. Paulsen SM, Killyon GW, Barillo DJ. High-frequency percussion ventilation as a salvage modality in adult respiratory distress syndrome. Am Surg 2002;68(10):852-856.
24. Salim A, Martin M. High-frequency percussive ventilation. Crit Care Med 2005;33(3):S241-S245.
25. Barach AL, Beck GL. Exsufflation with negative pressure. Arch Intern Med 1954;93(6):825-841.
26. Homnick DM. Mechanical insufflation-exsufflation for airway mucus clearance. Respir Care 2007;52(10):1296-1305.
27. Gomez-Merino E, Bach JR. Duchenne muscular dystrophy. Prolongation of life by noninvasive ventilation and mechanically assisted cough. Am J Phys Med Rehabil 2002;81(6):411-415.
28. Coplin WM, Pieson DJ, Cooley KD, Newell DW, Rubenfeld GD. Implications of extubation delay in brain-injured patients meeting standard weaning criteria. Am J Respir Crit Care Med 2000;161(5): 1530-1536.
29. Khamiees M, Raju P, DeGirolamo A, Amoateng-Adjepong Y, Manthous CA. Predictors of extubation outcome in patients who have successfully completed a spontaneous breathing trial. Chest 2001; 120(4):1262-1270.
30. Epstein SK, Ciubotaru RL, Wong JB. Effect of failed extubation on the outcome of mechanical ventilation. Chest 1997;112(1):186-192.
31. Rothaar RC, Epstein SK. Extubation failure: magnitude of the problem, impact on outcomes, and prevention. Curr Opin Crit Care 2003;9(1):59-66.
32. Vianello A, Arcaro G, Braccioni F, Gallan F, Marchi MR, Chizio S, et al. Prevention of extubation failure in high-risk patients with neuromuscular disease. J Crit Care 2011;26(5):517-524.
33. Goncalves MR, Honrado T, Winck JC, Paiva JR. Effects of mechanical insufflation-exsufflation in preventing respiratory failure after extubation: a randomized controlled trial. Crit Care 2012; 16(2):R48.
34. Rodriguez AME, Pravinkumar E. Mechanical insufflation-exsufflation and prevention of post-extubation acute respiratory failure: most welcome but must be used cautiously in critically ill patients. Crit Care 2012;16(3):431.
35. MacIntyre NR, Silver RM, Miller CW, Schuler F, Coleman RE. Aerosol delivery in intubated, mechanically ventilated patients. Crit Care Med 1985;13(2):81-84.
36. Ari A, Fink JB. Factors affecting bronchoodilator delivery in mechanically ventilated adults. Nursing Crit Care 2010;15(4):192-203.
37. Fuller HD, Dolovitch MB, Posmituck G, Pack WW, Newhouse MT. Pressurized aerosol versus jet aerosol delivery to mechanically ventilated patients. Comparison of dose to the lungs. Am Rev Respir Dis 1990;141(2):440-444.
38. Emberger JS, Brown JM, Killian L. Cost reduction using Aeroneb Solo in a medical ICU ventilator population [abstract]. Respir Care 2011;56(10):1700.
39. O'Riordan TG, Greco MJ, Perry RJ, Smaldone GC. Nebulizer function during mechanical ventilation. AmRev Respir Dis 1992;145(5): 1117-1122.
40. Dhand R, Guntur VP. How best to deliver aerosol medications to mechanically ventilated patients. Clin Chest Med 2008;29(2):277-296.
41. Duarte AG. Inhaled bronchodilator administration during mechanical ventilation. Respir Care 2004;49(6):623-634.
42. Dhand R, Jubran A, Tobin MJ. Bronchodilator delivery by metereddose inhaler in ventilator-supported patients. Am J Respir Crit Care Med 1995;151(6):1827-1833.
43. Rau JL, Dunlevy CL, Hill RL. A comparison of inline PMDI actuators for delivery of a beta agonist and a corticosteroid with a mechanically-ventilated lung model. Respir Care 1998;43(9):705-712.
44. Fink JB, Dhand R, Grychowski J, Fahey PJ, Tobin MJ. Reconciling in-vitro and in-vivo measurements of aerosol delivery from a metered dose inhaler during mechanical ventilation, and defining efficiency enhancing factors. Am J Respir Crit Care Med 1999;159(1): 63-68.
45. Lin HL, Fink JB, Zhou Y, Cheng YS. Influence of moisture accumulation in in-line space or on delivery of metered dose inhaler through mechanical ventilation. Respir Care 2009;54(10):1336-1341.
46. Diot P, Morra L, Smaldone GC. Albuterol delivery in a model of mechanical ventilation. Comparison of metered-dose inhaler and nebulizer efficiency. Am J Respir Crit Care Med 1995;152(4):1391-1394.
47. O'Doherty MJ, Thomas SH, Page CJ, Treacher DF, Nunan TO. Delivery of a nebulized aerosol to a lung model during mechanical ventilation. Effects of ventilator settings and nebulizer type, position and volume of fill. Am Rev Respir Dis 1992;146(2):383-388.
48. Harvey CJ, O'Doherty MJ, Page CJ, Thomas SH, Nunan TO, Treacher DF. Effect of a spacer on pulmonary aerosol deposition from a jet nebulizer during mechanical ventilation. Thorax 1995; 50(1):50-53.
49. Miller DD, Amin MM, Palmer LB, Shah AR, Smaldone GC. Aerosol delivery and modern mechanical ventilation. Am J Respir Crit Care Med 2003;168(10):1205-1209.
50. Alvine GF, Rodgers P, Fitzsimmons KM, Aherns RC. Disposable jet nebulizers. How reliable are they? Chest 1992;101(2):316-319.
51. Hughes JM, Saez J. Effects of nebulizer mode and position in a mechanical ventilator circuit on dose efficiency. Respir Care 1987; 32(12):1131-1135.
52. McPeck M, O'Riordan TG, Smaldone GC. Predicting aerosol delivery to intubated patients: influence of choice of mechanical ventilator on nebulizer efficiency. Respir Care 1993;38(8):887-895.
53. Harvey CJ, O'Doherty MJ, Page CJ, Thomas SH, Nunan TO, Treacher DF. Comparison of jet and ultrasonic nebulizer pulmonary aerosol deposition during mechanical ventilation. Eur Respir J 1997; 10(4):905-909.
54. Phillips GD, Millard FJC. The therapeutic use of ultrasonic nebulizers in acute asthma. Respir Med 1994;88(5):387-389.
55. Yeo LY, Friend JR, McIntosh MP, Meeusen EN, Morton DA. Ultrasonic nebulization platforms for pulmonary drug delivery. Expert Opin Drug Deliv 2010;7(6):663-679.
56. Steckel H, Eskandar F. Factors affecting aerosol performance during nebulization with jet and ultrasonic nebulizers. Eur J Pharm Sci 2003;19(5):443-455.
57. Ari A, Telli O, Harwood R, Sheard MM, Aljamhan EA, Fink JB. Influence of nebulizer type, position and bias flow on aerosol drug delivery in simulated pediatric and adult lung models during mechanical ventilation. Respir Care 2010;55(7):845-851.
58. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165(7):867-903.
59. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of of adults with hospitalacquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171(4):388-416.
60. Palmer LB. Aerosolized antibiotics in the intensive care unit. Clin Chest Med 2011;32(3):559-574.
61. Rello J, Mariscal D, March F, Jubert P, Sanchez F, Valles J, Coll P. Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients: relapse or reinfection? Am J Respir Crit Care Med 1998; 157(3):912-916.
62. Palmer LB. Aerosolized antibiotics in critically-ill ventilated patients. Curr Opin Crit Care 2009;15(5):413-418.
63. Kallet RH, Quinn T. The role of the gastrointestinal tract in development of ventilator-associated pneumonia. Respir Care 2005;50(7): 910-923.
64. Craven DE, Hjalmarson KI. Ventilator-associated tracheobronchitis and pneumonia: thinking outside the box. Clin Infect Dis 2010; 51(Suppl 1):S59-S66.
65. O'Riordan TG. Inhaled antimicrobial therapy: from cyctic fibrosis to the flu. Respir Care 2000;45(7):836-845.
66. Mohr AM, Sifri ZC, Horng HS, Sadek R, Savetamal A, Hauser CJ, Livingston DH. Use of aerosolized aminoglycosides in the treatment of gram-negative ventilator-associated pneumonia. Surg Infect 2007;8(3):349-357.
67. Palmer LB, Smaldone GC, Chen JJ, Baram D, Duan T, Monteforte M, et al. Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit. Crit Care Med 2008;36(7): 2008-2013.
68. Michalopoulos A, Fotakis D, Virtzili S, Vletsas C, Raftopoulou S, Mastora Z, Falagas ME. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram negative bacteria: a prospective study. Respir Med 2008; 102(3):407-412.
69. Ghannam DE, Rodriguez GH, Raad II, Safdar A. Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance. Eur J Clin Microbiol Infect Dis 2009;28(3): 253-259.
70. Czosnowski QA, Wood GC, Magnotti LJ, Croce MA, Swanson JM, Boucher BA, Fabian TC. Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia. Pharmacotherapy 2009;29(9):1054-1060.
71. Lin C-C, Liu T-C, Kuo C-F, Liu C-P, Lee C-M. Aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii pneumonia: experience in a tertiary care hospital in Northern Taiwan. J Microbiol Immunol Infect 2010;43(4):323-331.
72. Lu Q, Yang J, Gutierrez C, Aymard G, Rouby J-J, and the Nebulized Antibiotics Study Group. Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Am J Respir Crit Care Med 2011;184(1):106-115.
73. Arnold HM, Sawyer AM, Kollef MH. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia. Respir Care 2012;57(8):1226-1233.
74. LeConte P, Potel G, Clemente E, Legras A, Villers D, Bironneau E, et al. Administration of tobramycin aerosols in patients with nosocomial pneumonia: a preliminary study. Presse Med 2000;29(2): 76-78.
75. Wood GC, Boucher BA, Croce MA, Hanes SD, Herring VL, Fabian TC. Aerosolized ceftazidime for prevention of ventilator-associated pneumonia and drug effects on the pro-inflammatory response in critically-ill trauma patients. Pharmacotherapy 2002;22(8):972-982.
76. Claridge JA, Edwards NM, Swanson J, Fabian TC, Weinberg JA, Wood GC, Croce MA. Aerosolized ceftazidime prophylaxis against ventilator-associated pneumonia in high-risk trauma patients: results of a double-blind randomized study. Surg Infect 2007;8(1): 83-90.
77. Hallal A, Cohn SM, Namias N, Habib F, Baracco G, Manning RJ et. al. Aerosolized tobramycin in the treatment of ventilator-associated pneumonia: a pilot study. Surg Infect 2007;8(1):73-81.
78. Cook DJ, Walter SD, Cook RJ, Griffith LE, Guyatt GH, Leasa D, et. al. Incidence of and risk factors for ventilator-associated pneumonia in critically-ill patients. Ann Intern Med 1998;129(6):433-440.
79. Klastersky J, Huysmans E, Weerts D, Daneau D. Endotracheally administration of gentamycin for the prevention of infections of the respiratory tract in patients with tracheostomy: a double-blind study. Chest 1974;65(6):650-654.
80. Feeley TW, du Moulin GC, Hedley-Whyte J, Bushnell LS, Gilbert JP, Feingold DS. Aerosolized polymyxin and pneumonia in seriously ill patients. N Engl J Med 1975;293(10): 471-475.
81. Bigatello LM, Hurford WE, Kacmarek RM, Roberts JD, Zapol WM. Prolonged inhalation of low concentrations of nitric oxide in patients with sever adult respiratory distress syndrome. Anesthesiology 1994;80(4):761-770.
82. Walmrath D, Schneider T, Pilch J, Grimminger F, Seeger W. Aerosolized prostacyclin in adult respiratory distress syndrome. Lancet 1993;342(8877):961-962.
83. Camamo JM, McCoy RH, Erstad BL. Retrospective evaluation of inhaled prostaglandins in patients with acute respiratory distress syndrome. Pharmacotherapy 2005;25(2):184-190.
84. Bein T, Metz C, Cornelius K, Sendtner E, Pfeifer M. Cardiovascular and pulmonary effects of aerosolized prostacyclin administration in severe respiratory failure using a ventilator nebulization system. J Cardiovasc Pharmacol 1996;27(4):583-586.
85. Domenighetti G, Stricker H, Waldispuehl B. Nebulized prostacyclin (PGI2) in acute respiratory distress syndrome: impact of primary (pulmonary injury) and secondary (extrapulmonary injury) disease on gas exchange response. Crit Care Med 2001;29(1):57-62.
86. Siobal MS, Hess DR. Are inhaled vasodilators useful in acute lung injury and acute respiratory distress syndrome? Respir Care 2010; 55(2):144-157.
87. Dellinger RP, Zimmerman JL, Taylor RW, Straube RC, Hauser DL, Criner GJ, et al. Effects of inhaled nitric oxide in patients with acute respiratory distress: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med 1998;26(1): 15-23.
88. Michael JR, Barton RG, Saffle JR, Mone M, Markewitz BA, Hillier K, et al. Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care Med 1998;157(5): 1372-1380.
89. Lundin S, Mang H, Smithes M, Stenqvist O, Frostell C. Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. European Study Group of Inhaled Nitric Oxide. Intensive Care Med 1999;25(9):911-919.
90. Mehta S, Simms HH, Levy MM, Hill NS, Schwartz W, Nelson D, et al. Inhaled nitric oxide improves oxygenation acutely but not chronically in acute respiratory distress syndrome: a randomized controlled trial. J Appl Res 2001;1(2):73-84.
91. vanHeerden PV, Barden A, Michalopoulos N, Bulsara MK, Roberts BL. Dose-response to inhaled aerosolized prostacyclin for hypoxemia due to ARDS. Chest 2000;117(3):819-827.
92. Pappert D, Busch T, Gerlach H, Lewandowski K, Radermacher P, Rossaint R. Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome. Anesthesiol 1995;82(6):1507-1511.
93. vanHeerden PV, Webb SAR, Hee G, Corkeron M, Thompson WR. Inhaled aerosolized prostacyclin as a selective pulmonary vasodilator for the treatment of severe hypoxemia. Anaesth Intensive Care 1996;24(1):87-90.
94. Siobal MS, Kallet RH, Pittet J-F, Warnecke EL, Kraemer RW, Venkayya RV, Tang JF. Description and evaluation of a delivery system for aerosolized prostacyclin. Respir Care 2003;48(8):742-753.
95. McMillen JC, Burke CF, Dhingra A, Dudney TM, Faircloth BE. Use of inhaled epoprostenol in patients with H1N1 influenza-associated acute respiratory distress syndrome: a case series. Ann Pharmacother 2011;45(5):e25.
96. Ciencewicki J, Trivedia S, Kleeberger SR. Oxidants in the pathogenesis of lung diseases. J Allergy Clin Immunol 2008;122(3):456-468.
97. Haber O, Kleen M, Zwissler B, Pusch R, Welte M, Vogelmeier C, Kempter B, et al. Inhalation of prostacyclin (PGI2) for 8 hours does not produce signs of acute pulmonary toxicity in healthy lambs. Intensive Care Med 1996;22(11):426-433.
98. vanHeerden PV, Caterina P, Filion P, Spagnolo DV, Gibbs NM. Pulmonary toxicity of inhaled aerosolized prostacyclin therapy-an observational study. Anaesth Intensive Care 2000;28(2):161-166.
99. Thompson PB, Herndon DN, Taber DL, Abston S. Effect on mortality of inhalation injury. J Trauma 1986;26(2):163-165.
100. Hollingsed TC, Saffle JR, Barton RG, Craft WB, Morris SE. Etiology and consequences of respiratory failure in thermally injured patients. Am J Surg 1993;166(6):592-596.
101. Zikria BA, Weston GC, Chodoff M, Ferrer JM. Smoke and carbon monoxide poisoning in fire victims. J Trauma 1972;12(8):641-645.
102. Chong SJ, Song C, Tan TW, Kusumawijaja G, Chew KY. Multivariate analysis of burn patients in the Singapore General Hospital Burn Centre (2003-2005). Burns 2009;35(2):215-220.
103. Desai MH, Mlcak R, Richardson J, Nichols R, Herndon DN. Reduction in mortality in pediatric patients with inhalation injury with aerosolized heparin/acetylcystine therapy. J Burn Care Rehabil 1998; 19(3):210-212.
104. Miller AC, Rivero A, Ziad S, Smith DJ, Elamin EM. Influence of nebulized unfractionated heparin and N-acetylcysteine in acute lung injury after smoke inhalation injury. J Burn Care Res 2009;30(2): 249-256.
105. Yip LY, Lim YF, Chan HN. Safety and potential anticoagulant effects of nebulized heparin in burn patients with inhalational injury at Singapore General Hospital Burn Centre. Burns 2011;37(7):1154-1160.
106. Murakami K, McGuire R, Cox RA, Jodoin MJ, Bjertnaes LJ, Katahira J, et al. Heparin nebulization attenuates acute lung injury in sepsis following smoke inhalation in sheep. Shock 2002;18(3): 236-241.
107. Enkbaatar P, Cox RA, Traber LD, Westphal M, Aimalohi E, Morita N, et al. Aerosolized anticoagulants ameliorate acute lung injury in sheep after exposure to burn and smoke inhalation. Crit Care Med 2007;35(12):2805-2810.
108. Chopra A, Burkey B, Calaman S. A case report of clinically significant coagulopathy associated with aerosolized heparin and acetlycysteine therapy for inhalation injury. Burns 2011;37(7):e73-e75.
109. Dixon B, Santamaria JD, Campbell DJ. A phase 1 trial of nebulized heparin in acute lung injury. Crit Care 2008;12(3):R64.
110. Robinson BRH, Athota KP, Branson RD. Inhalational therapies for the ICU. Curr Opin Crit Care 2009;15(1):1-9.
111. Shiue ST, Gluck EH. The use of helium-oxygen mixtures in the support of patients with status asthmaticus and respiratory acidosis. J Asthma 1989;26(3):177-180.
112. Colebourn CL, Barber V, Young JD. Use of helium-oxygen mixture in adult patients presenting with excacerbations of asthma and chronic obstructive pulmonary disease: a systematic review. Anaesthesia 2007;62(1):34-42.
113. Leit JM, Ducruet T, Gupta V, Cambonie G. Heliox inhalation ther-apy for bronchiolitis in infants. Cochrane Database Syst Rev 2010; 14(4):CD006915.
114. Vorwerk C, Coates T. Best evidence topic reports: heliox in croup. Emerg J Med 2008;25(9):365-366.
115. Gentile MA. Inhaled medical gases: more to breathe than oxygen. Respir Care 2011;56(9):1341-1357.
116. Gluck EH, Onorato DJ, Castriotta R. Helium-oxygen mixtures in intubated patients with status asthmaticus and respiratory acidosis. Chest 1990;98(3):693-698.
117. Abd-Allah SA, Rogers MS, Terry M, Gorss M, Perkin RM. Helium-oxygen therapy for pediatric acute severe asthma requiring mechanical ventilation. Pediatr Crit Care 2003;4(3):353-357.
118. Szczapa T, Gadzinowski J. Use of heliox in the management of neonates with meconium aspiration syndrome. Neonatology 2011; 100(3):265-270.
119. Gupta VK, Grayck EN, Cheifetz IM. Heliox administration during high-frequency jet ventilation augments carbon dioxide clearance. Respir Care 2004;49(9):1038-1044.